[1]
|
Kloos, W.E. (1997) Taxonomy and Systematic of Staphylococci Indigenous to Humans. In: Crossley, K.B. and Archer, G.L., Eds., The Staphylococci in Human Disease, Churchill Livingstone, New York, 113-137.
|
[2]
|
Wilson, LG. (1987) The Early Recognition of Streptococci as Causes of Disease. Medical History, 31, 403-414. https://doi.org/10.1017/S0025727300047268
|
[3]
|
Rosenbach, F.J. (1884) Microorganisms in the Wound Infections Diseases of Man. J.F. Bergmann, Wiesbaden, 18.
|
[4]
|
Stryjewski, M.E. and Corey, G.R. (2014) Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen. Clinical Infectious Diseases, 58, S10-S19.
https://doi.org/10.1093/cid/cit613
|
[5]
|
Wertheim, H.F., Melles, D.C., Vos, M.C., et al. (2005) The Role of Nasal Carriage in Staphylococcus aureus Infections. The Lancet Infectious Diseases, 5, 751-762.
https://doi.org/10.1016/S1473-3099(05)70295-4
|
[6]
|
Lowy, F.D. (1998) Staphylococcus aureus Infections. The New England Journal of Medicine, 339, 520-532. https://doi.org/10.1056/NEJM199808203390806
|
[7]
|
Peacock, S.J. and Paterson, G.K. (2015) Mechanisms of Methicillin Resistance in Staphylococcus aureus. Annual Review of Biochemistry, 84, 577–601.
https://doi.org/10.1146/annurev-biochem-060614-034516
|
[8]
|
Tong, S.Y.C., Davis, J.S., Eichenberger, E., et al. (2015) Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management. Clinical Microbiology Reviews, 28, 603-661. https://doi.org/10.1128/CMR.00134-14
|
[9]
|
Vandenesch, F., Lina, G. and Henry, T. (2012) Staphylococcus aureus Hemolysins, bi-Component Leukocidins, and Cytolytic Peptides: A Redundant Arsenal of Membrane-Damaging Virulence Factors? Frontiers in Cellular and Infection Microbiology, 2, 2-13. https://doi.org/10.3389/fcimb.2012.00012
|
[10]
|
Costerton, J.W., Lewandowski, Z., Caldwell, D.E., et al. (1995) Microbial Biofilms. Annual Review of Microbiology, 49, 711–745.
https://doi.org/10.1146/annurev.mi.49.100195.003431
|
[11]
|
Otto, M. (2013) Staphylococcal Infections: Mechanisms of Biofilm Maturation and Detachment as Critical Determinants of Pathogenicity. Annual Review of Medicine, 64, 175-188. https://doi.org/10.1146/annurev-med-042711-140023
|
[12]
|
Amulic, B., Cazalet, C., Hayes, G.L., Metzler, K.D. and Zychlinsky, A. (2012) Neutrophil Function: From Mechanisms to Disease. Annual Review of Immunology, 30, 459-489. https://doi.org/10.1146/annurev-immunol-020711-074942
|
[13]
|
Spaan, A.N., Surewaard, B.G.J., Nijland, R., et al. (2013) Neutrophils versus Staphylococcus aureus: A Biological Tug of War. Annual Review of Microbiology, 67, 629-650. https://doi.org/10.1146/annurev-micro-092412-155746
|
[14]
|
Greenlee-Wackera, M., DeLeod, F.R. and Nauseef, W.M. (2015) How Methicillin-Resistant Staphylococcus aureus Evade Neutrophil Killing. Wolters Kluwer Health, 22, 31-35.
|
[15]
|
Boucher, H.W. and Corey, G.R. (2008) Epidemiology of Methicillin-Resistant Staphylococcus aureus. Clinical Infectious Diseases, 46, S344-S349.
https://doi.org/10.1086/533590
|
[16]
|
Archer, G.L. (1998) Staphylococcus aureus: A Well-Armed Pathogen. Clinical Infectious Diseases, 26, 1179-1181. https://doi.org/10.1086/520289
|
[17]
|
Baker, A.D.L. and Macnicol, M.F. (2008) Haematogenous Osteomyelitis in Children: Epidemiology, Classification, Aetiology and Treatment. Journal of Paediatrics and Child Health, 18, 75-84. https://doi.org/10.1016/j.paed.2007.11.002
|
[18]
|
Shorr, A.F., Tabak, Y.P., Gupta, V., et al. (2006) Morbidity and Cost Burden of Methicillin-Resistant Staphylococcus aureus in Early Onset Ventilator Associated Pneumonia. Critical Care, 10, R97. https://doi.org/10.1186/cc4934
|
[19]
|
Lambert, M.L., Suetens, C., Savey, A., et al. (2011) Clinical Outcomes of Health-Care-Associated Infections and Antimicrobial Resistance in Patients Admitted to European Intensive-Care Units: A Cohort Study. The Lancet Infectious Diseases, 11, 30-38. https://doi.org/10.1016/S1473-3099(10)70258-9
|
[20]
|
Cosgrove, S.E., Qi, Y., Kaye, K.S., et al. (2005) The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges. Infection Control and Hospital Epidemiology, 26, 166-174. https://doi.org/10.1086/502522
|
[21]
|
McHugh, C.G. and Riley, L.W. (2004) Risk Factors and Costs Associated with Methicillin-Resistant Staphylococcus aureus bloodstream infections. Infection Control and Hospital Epidemiology, 25, 425-430. https://doi.org/10.1086/502417
|
[22]
|
Klevens, R.M., Morrison, M.A., Nadle, J., et al. (2007) Invasive Methicillin Resistant Staphylococcus aureus Infections in the United States. JAMA, 298, 1763-1771.
https://doi.org/10.1001/jama.298.15.1763
|
[23]
|
Chang, V.S., Dhaliwal, D.K., et al. (2015) Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: A 20-Year Review. Wolters Kluwer Health, 34, 698-703. https://doi.org/10.1097/ICO.0000000000000431
|
[24]
|
Paterson, G.K., Harrison, E.M. and Holmes, M.A. (2014) The Emergence of mecC Methicillin-Resistant Staphylococcus aureus. Trends in Microbiology, 22, 42-47.
https://doi.org/10.1016/j.tim.2013.11.003
|
[25]
|
National Nosocomial Infections Surveillance (NNIS) (2004) System Report, Data Summary from January 1992 through June 2004, Issued October 2004. American Journal of Infection Control, 32, 470-485. https://doi.org/10.1016/j.ajic.2004.10.001
|
[26]
|
Chambers, H.F. (2001) The Changing Epidemiology of Staphylococcus aureus? Emerging Infectious Diseases, 7, 178-182. https://doi.org/10.3201/eid0702.010204
|
[27]
|
Grundmann, H., Aires-de-Sousa, M., Boyce, J., et al. (2006) Emergence and Resurgence of Meticillin-Resistant Staphylococcus aureus as a Public-Health Threat. The Lancet, 368, 874-885. https://doi.org/10.1016/S0140-6736(06)68853-3
|
[28]
|
Centers for Disease Control and Prevention (1999) Four Pediatric Deaths from Community-Acquired Methicillin-Resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA, 282, 1123-1125.
|
[29]
|
Herold, B.C., Immergluck, L.C., Maranan, M.C., et al. (1998) Community-Acquired Methicillin-Resistant Staphylococcus aureus in Children with No Identified Predisposing Risk. JAMA, 279, 593-598. https://doi.org/10.1001/jama.279.8.593
|
[30]
|
Boye, K., Bartels, M.D., Andersen, I.S., et al. (2007) A New Multiplex PCR for Easy Screening of Methicillin-Resistant Staphylococcus aureus SCCmec Types I-V. Clinical Microbiology and Infection, 13, 725-727.
https://doi.org/10.1111/j.1469-0691.2007.01720.x
|
[31]
|
Gostev, V.V. and Sidorenko, S.V. (2012) Staphylococcal Cassette Chromosome Mec, Evolution and Genetic Lines of Methicillin-Resistant Staphylococcus aureus. Antibiotiki i khimioterapiia, 57, 38-46.
|
[32]
|
Al-Zubeidi, D., Hogan, P.G., Boyle, M., et al. (2014) Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Isolated in Serial Cultures from the Respiratory Tract of Children with Cystic Fibrosis. Pediatric Infectious Disease Journal, 33, 549-553. https://doi.org/10.1097/INF.0000000000000204
|
[33]
|
Anonymity (2010) MRSA Infections Decline, But New Bacterial Strains Threaten. You Can Take Action to Protect Yourself against Drug-Resistant Bacteria. Duke Medicine Health News, 16, 7.
|
[34]
|
Perencevich, E.N. and Diekema, D.J. (2010) Decline in Invasive MRSA Infection: Where to Go from Here? JAMA, 304, 687-689.
https://doi.org/10.1001/jama.2010.1125
|
[35]
|
Usui, J., Kobayashi, M., Ebihara, I., et al. (2011) Methicillin-Resistant Staphylococcus-aureus-Associated Glomerulonephritis on the Decline: Decreased Incidence since the 1990s. Clinical and Experimental Nephrology, 15, 184-186.
https://doi.org/10.1007/s10157-010-0369-x
|
[36]
|
Eells, S.J., Mckinnell, J.A., Wang, A.A., et al. (2013) A Comparison of Clinical Outcomes between Healthcare-Associated Infections Due to Community-Associated Methicillin-Resistant Staphylococcus aureus Strains and Healthcare-Associated Methicillin-Resistant S. aureus Strains. Epidemiology and Infection, 141, 1-14.
https://doi.org/10.1017/S0950268812002634
|
[37]
|
Gottlieb, T., Su, W.Y., Merlino, J., et al. (2008) Recognition of USA300 Isolates of Community-Acquired Methicillin-Resistant Staphylococcus aureus in Australia. The Medical Journal of Australia, 189, 179-180.
|
[38]
|
Tenover, F.C. and Goering, R.V. (2009) Methicillin-Resistant Staphylococcus aureus Strain USA300: Origin and Epidemiology. Journal of Antimicrobial Chemotherapy, 64, 441-446. https://doi.org/10.1093/jac/dkp241
|
[39]
|
Larsen, A.R., Bocher, S., Stegger, M., et al. (2008) Epidemiology of European Community-Associated Methicillin-Resistant Staphylococcus aureus Clonal Complex 80 Type IV Strains Isolated in Denmark from 1993 to 2004. Journal of Clinical Microbiology, 46, 62-68. https://doi.org/10.1128/JCM.01381-07
|
[40]
|
Moellering, R.C. (2010) Why Has Methicillin-Resistant Staphylococcus aureus Become Such a Successful Pathogen in Adults? Infectious Diseases in Clinical Practice, 18, 286-291. https://doi.org/10.1097/IPC.0b013e3181efebca
|
[41]
|
Uhlemann, A.-C., Otto, M., Lowy, F.D., et al. (2014) Evolution of Community- and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus. Infection, Genetics and Evolution, 21, 563-574. https://doi.org/10.1016/j.meegid.2013.04.030
|
[42]
|
Levine, D.P., Cushing, R.D., Jui, J., et al. (1982) Community-Acquired Methicillin-Resistant Staphylococcus aureus Endocarditis in the Detroit Medical Center. Annals of Internal Medicine, 97, 330-338.
https://doi.org/10.7326/0003-4819-97-3-330
|
[43]
|
Udo, E.E., Pearman, J.W. and Grubb, W.B. (1993) Genetic Analysis of Community Isolates of Methicillin-Resistant Staphylococcus aureus in Western Australia. Journal of Hospital Infection, 25, 97-108. https://doi.org/10.1016/0195-6701(93)90100-E
|
[44]
|
Dufour, P., Gillet, Y., Bes, M., et al. (2002) Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in France: Emergence of a Single Clone That Produces Panton-Valentine Leukocidin. Clinical Infectious Diseases, 35, 819-824. https://doi.org/10.1086/342576
|
[45]
|
Ma, X.X., Galiana, A., Pedreira, W., et al. (2005) Community-Acquired Methicillin-Resistant Staphylococcus aureus, Uruguay. Emerging Infectious Diseases, 11, 973-976. https://doi.org/10.3201/eid1106.041059
|
[46]
|
Wang, C.C., Lo, W.T., Chu, M.L., et al. (2004) Epidemiological Typing of Community-Acquired Methicillin-Resistant Staphylococcus aureus Isolates from Children in Taiwan. Clinical Infectious Diseases, 39, 481-487.
https://doi.org/10.1086/422642
|
[47]
|
Pallin, D.J., Egan, D.J., Pelletier, A.J., et al. (2008) Increased US Emergency Department Visits for Skin and Soft Tissue Infections, and Changes in Antibiotic Choices, during the Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus. Annals of Emergency Medicine, 51, 291-298.
https://doi.org/10.1016/j.annemergmed.2007.12.004
|
[48]
|
Moran, G.J., Krishnadasan, A., Gorwitz, R.J., et al. (2006) Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department. New England Journal of Medicine, 355, 666-674. https://doi.org/10.1056/NEJMoa055356
|
[49]
|
Nimmo, G.R. (2012) USA300 Abroad: Global Spread of a Virulent Strain of Community-Associated Methicillin-Resistant Staphylococcus aureus. Clinical Microbiology and Infection, 18, 725-734. https://doi.org/10.1111/j.1469-0691.2012.03822.x
|
[50]
|
Thurlow, L.R., Joshi, G.S. and Richardson, A.R. (2012) Virulence Strategies of the Dominant USA300 Lineage of Community Associated Methicillin Resistant Staphylococcus aureus (CA-MRSA). FEMS Immunology & Medical Microbiology, 65, 5-22. https://doi.org/10.1111/j.1574-695X.2012.00937.x
|
[51]
|
King, M.D., Humphrey, B.J., Wang, Y.F., et al. (2006) Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 300 Clone as the Predominant Cause of Skin and Soft-Tissue Infections. Annals of Internal Medicine, 144, 309-317. https://doi.org/10.7326/0003-4819-144-5-200603070-00005
|
[52]
|
Reyes, J., Rincon, S., Diaz, L., et al. (2009) Dissemination of Methicillin-Resistant Staphylococcus aureus USA300 Sequence Type 8 Lineage in Latin America. Clinical Infectious Diseases, 49, 1861-1867. https://doi.org/10.1086/648426
|
[53]
|
Hota, B., Lyles, R., Rim, J., et al. (2011) Predictors of Clinical Virulence in Community-Onset Methicillin-Resistant Staphylococcus aureus Infections. Clinical Infectious Diseases, 53, 757-765. https://doi.org/10.1093/cid/cir472
|
[54]
|
Dantes, R., Mu, Y., Belflower, R., et al. (2013) National Burden of Invasive Methicillin-Resistant Staphylococcus aureus Infections, United States, 2011. JAMA Internal Medicine, 173, 1970-1978.
|
[55]
|
Nimmo, G.R., Pearson, J.C., Collignon, P.J., et al. (2011) Antimicrobial Susceptibility of Staphylococcus aureus Isolated from Hospital Inpatients, 2009: Report from the Australian Group on Antimicrobial Resistance. Communicable Diseases Intelligence, 35, 237-243.
|
[56]
|
Styers, D., Sheehan, D.J., Hogan, P., et al. (2006) Laboratory-Based Surveillance of Current Antimicrobial Resistance Patterns and Trends among Staphylococcus aureus: 2005 Status in the United States. Annals of Clinical Microbiology and Antimicrobials, 5, 1-9. https://doi.org/10.1186/1476-0711-5-1
|
[57]
|
Public Health England (2013) Voluntary Reporting of Staphylococcus aureus Bacteraemia in England, Wales and Northern Ireland, 2012. Health Protection Report.
|
[58]
|
Huang, Y.-C. and Chen, C.-J. (2011) Community-Associated Meticillin-Resistant Staphylococcus aureus in Children in Taiwan, 2000s. International Journal of Antimicrobial Agents, 38, 2-8. https://doi.org/10.1016/j.ijantimicag.2011.01.011
|
[59]
|
Otter, J.A. and French, G.L. (2010) Molecular Epidemiology of Community-Associated Meticillin-Resistant Staphylococcus aureus in Europe. Lancet Infectious Diseases, 10, 227-239. https://doi.org/10.1016/S1473-3099(10)70053-0
|
[60]
|
Rammelkamp, C.H. and Maxon, T. (1942) Resistance of Staphylococcus aureus to the Action of Penicillin. Experimental Biology and Medicine, 51, 386-389.
https://doi.org/10.3181/00379727-51-13986
|
[61]
|
Bondi, A. and Dietz, C.C. (1945) Penicillin Resistant Staphylococci. Experimental Biology and Medicine, 60, 55-58. https://doi.org/10.3181/00379727-60-15089
|
[62]
|
Kirby, W.M. (1944) Extraction of a Highly Potent Penicillin Inactivator from Penicillin Resistant Staphylococci. Science, 99, 452-453.
https://doi.org/10.1126/science.99.2579.452
|
[63]
|
Finland, M. (1955) Emergence of Antibiotic-Resistant Bacteria. New England Journal of Medicine, 253, 909-922. https://doi.org/10.1056/NEJM195511242532105
|
[64]
|
Brumfitt, W. and Hamilton-Miller, J. (1989) Methicillin-Resistant Staphylococcus aureus. New England Journal of Medicine, 320, 1188-1196.
https://doi.org/10.1056/NEJM198905043201806
|
[65]
|
Jessen, O., Rosendal, K., Bulow, P., Faber, V., Eriksen, K.R. (1969) Changing Staphylococci and Staphylococcal Infections. A Ten-Year Study of Bacteria and Cases of Bacteremia. New England Journal of Medicine, 281, 627-635.
https://doi.org/10.1056/NEJM196909182811201
|
[66]
|
Jevons, M.P. (1961) “Celbenin”-Resistant Staphylococci. British Medical Journal, 1, 124-125. https://doi.org/10.1136/bmj.1.5219.124-a
|
[67]
|
Stefani, S., Campanile, F., Santagati, M., et al. (2015) Insights and Clinical Perspectives of Daptomycin Resistance in Staphylococcus aureus: A Review of the Available Evidence. International Journal of Antimicrobial Agents, 8, 1-12.
|
[68]
|
Centers for Disease Control and Prevention (CDC) (2002) Staphylococcus aureus Resistant to Vancomycin—United States, 2002. MMWR. Morbidity and Mortality Weekly Report, 51, 565-567.
|
[69]
|
Lowy, F.D. (2003) Antimicrobial Resistance: The Example of Staphylococcus aureus. Journal of Clinical Investigation, 111, 1265-1273.
https://doi.org/10.1172/JCI18535
|
[70]
|
Malachowa, N. and DeLeo, F.R. (2010) Mobile Genetic Elements of Staphylococcus aureus. Cellular and Molecular Life Sciences, 67, 3057-3071.
https://doi.org/10.1007/s00018-010-0389-4
|